Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Molecular Genetics and Genomic Medicine is Scopus-indexed (Q3, CiteScore 3.1), WoS SCIE, DOAJ. Published by John Wiley and Sons Inc.
Checked against the index lists dated .
ISSN 2324-9269Verify ISSN ↗
Publisher: John Wiley and Sons Inc
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics (clinical) | 64 / 100 | 36th | Q3 |
| Genetics | 242 / 357 | 32nd | Q3 |
| Molecular Biology | 315 / 414 | 24th | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2013–present, best quartile Q3, CiteScore 3.1.
Molecular Genetics and Genomic Medicine is Q3 in Genetics (clinical) (rank 64 of 100), Q3 in Genetics (rank 242 of 357) and Q4 in Molecular Biology (rank 315 of 414), by CiteScore 2025.
Molecular Genetics and Genomic Medicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.1, which places it in quartile Q3 at the 36th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.596, quartile Q3, with an H-index of 50.
The publisher lists an article processing charge of about US$2,900 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Molecular Genetics and Genomic Medicine is published by John Wiley and Sons Inc. Its ISSN is 2324-9269.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Molecular Genetics and Genomic Medicine has an h-index of 58 and a 2-year mean of 1.46 citations per paper (OpenAlex). Its Scopus CiteScore is 3.1, quartile Q3. On 2-year citations it ranks #64 of 99 Scopus journals in Genetics (clinical).
Molecular Genetics and Genomic Medicine published 150 papers in 2025; its busiest recent year was 2019 with 573. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from China (55%), United States (8.3%) and South Africa (3.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 54 retracted papers are recorded (18.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.